Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

New HIV protease inhibitors reported by Searle

June 18, 1998

Agouron and Immune Response collaborate on the commercialization of Remune

June 16, 1998

DNA constructs encoding HIV-1 genes induce cellular cytotoxicity in humans

June 15, 1998

Data safety monitoring board recommends continuation of Remune phase III trial

June 15, 1998

DuPont Merck seeks FDA approval for Sustiva

June 12, 1998

CNI-H0294, an anti-HIV agent with a unique mechanism of action

June 11, 1998

Novopharm Biotech completes patient enrollment for GPI-2A phase Ia trial

June 10, 1998

Cel-Sci's improved AIDS vaccine recognizes most prevalent strains of virus

June 8, 1998

FDA gives VaxGen the go-ahead for phase III testing of AIDSVAX; trials will begin this month

June 4, 1998

Reticulose stimulates immune system in HIV-infected patients

June 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.